Any reasonable person would expect the company to trumpet having met the primary and/or secondary endpoints on PDD, no?
Why would a company not start a phase 3 after 2 years from initial results?
Why would a company not start all other trials for A2-73?
It puzzles me that company is not starting basket trial for A3-71?
Short on answers like everyone else.
Its positive to see institutional holdings around 35%+
Not sure what to make of the MOC trades we had at end of day for the last 1-2 months (it puzzled me when company traded over 100,000,000,000 shares in one day), at some point in the future - i would expect trading to revert to 400-500,000 shares per day
Market Data 
Markets 
AI
